Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

BZ vs SPIR vs ASTS vs RCUS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
BZ
Kanzhun Limited

Staffing & Employment Services

IndustrialsNASDAQ • CN
Market Cap$12.38B
5Y Perf.-64.1%
SPIR
Spire Global, Inc.

Specialty Business Services

IndustrialsNYSE • US
Market Cap$529.86B
5Y Perf.-79.8%
ASTS
AST SpaceMobile, Inc.

Communication Equipment

TechnologyNASDAQ • US
Market Cap$19.12B
5Y Perf.+405.0%
RCUS
Arcus Biosciences, Inc.

Biotechnology

HealthcareNYSE • US
Market Cap$2.50B
5Y Perf.-9.7%

BZ vs SPIR vs ASTS vs RCUS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
BZ logoBZ
SPIR logoSPIR
ASTS logoASTS
RCUS logoRCUS
IndustryStaffing & Employment ServicesSpecialty Business ServicesCommunication EquipmentBiotechnology
Market Cap$12.38B$529.86B$19.12B$2.50B
Revenue (TTM)$8.01B$72M$71M$236M
Net Income (TTM)$2.49B$-25.02B$-342M$-369M
Gross Margin84.5%40.8%53.4%90.7%
Operating Margin26.9%-121.4%-405.7%-168.6%
Forward P/E1.7x10.0x
Total Debt$302M$8.76B$32M$99M
Cash & Equiv.$2.55B$24.81B$2.34B$222M

BZ vs SPIR vs ASTS vs RCUSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

BZ
SPIR
ASTS
RCUS
StockJun 21May 26Return
Kanzhun Limited (BZ)10035.9-64.1%
Spire Global, Inc. (SPIR)10020.2-79.8%
AST SpaceMobile, In… (ASTS)100505.0+405.0%
Arcus Biosciences, … (RCUS)10090.3-9.7%

Price return only. Dividends and distributions are not included.

Quick Verdict: BZ vs SPIR vs ASTS vs RCUS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: BZ leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. AST SpaceMobile, Inc. is the stronger pick specifically for growth and revenue expansion. RCUS also leads in specific categories worth noting. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
BZ
Kanzhun Limited
The Income Pick

BZ carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.

  • Dividend streak 1 yrs, beta 1.22
  • Lower volatility, beta 1.22, Low D/E 2.0%, current ratio 3.60x
  • Beta 1.22, current ratio 3.60x
  • Better valuation composite
Best for: income & stability and sleep-well-at-night
SPIR
Spire Global, Inc.
The Value Angle

SPIR lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: industrials exposure
ASTS
AST SpaceMobile, Inc.
The Growth Play

ASTS is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.

  • Rev growth 15.1%, EPS growth 30.9%, 3Y rev CAGR 72.5%
  • 5.7% 10Y total return vs RCUS's 45.9%
  • 15.1% revenue growth vs SPIR's -35.2%
Best for: growth exposure and long-term compounding
RCUS
Arcus Biosciences, Inc.
The Momentum Pick

RCUS is the clearest fit if your priority is momentum.

  • +209.6% vs BZ's -9.4%
Best for: momentum
See the full category breakdown
CategoryWinnerWhy
GrowthASTS logoASTS15.1% revenue growth vs SPIR's -35.2%
ValueBZ logoBZBetter valuation composite
Quality / MarginsBZ logoBZ31.1% margin vs SPIR's -349.6%
Stability / SafetyBZ logoBZBeta 1.22 vs SPIR's 2.93, lower leverage
DividendsTieNone of these 4 stocks pay a meaningful dividend
Momentum (1Y)RCUS logoRCUS+209.6% vs BZ's -9.4%
Efficiency (ROA)BZ logoBZ11.7% ROA vs SPIR's -47.3%, ROIC 7.3% vs -0.1%

BZ vs SPIR vs ASTS vs RCUS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

BZKanzhun Limited
FY 2024
Online Recruitment Services To Enterprises Customers
98.8%$7.3B
Others
1.2%$86M
SPIRSpire Global, Inc.

Segment breakdown not available.

ASTSAST SpaceMobile, Inc.
FY 2025
Product
62.6%$44M
Service
37.4%$27M
RCUSArcus Biosciences, Inc.
FY 2025
License And Development Services
87.4%$221M
Development Services
6.7%$17M
R&D Services
3.2%$8M
License
2.8%$7M

BZ vs SPIR vs ASTS vs RCUS — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLBZLAGGINGRCUS

Income & Cash Flow (Last 12 Months)

BZ leads this category, winning 4 of 6 comparable metrics.

BZ is the larger business by revenue, generating $8.0B annually — 113.0x ASTS's $71M. BZ is the more profitable business, keeping 31.1% of every revenue dollar as net income compared to SPIR's -349.6%. On growth, ASTS holds the edge at +27.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricBZ logoBZKanzhun LimitedSPIR logoSPIRSpire Global, Inc.ASTS logoASTSAST SpaceMobile, …RCUS logoRCUSArcus Biosciences…
RevenueTrailing 12 months$8.0B$72M$71M$236M
EBITDAEarnings before interest/tax$2.2B-$74M-$237M-$391M
Net IncomeAfter-tax profit$2.5B-$25.0B-$342M-$369M
Free Cash FlowCash after capex$3.3B-$16.2B-$1.1B-$489M
Gross MarginGross profit ÷ Revenue+84.5%+40.8%+53.4%+90.7%
Operating MarginEBIT ÷ Revenue+26.9%-121.4%-4.1%-168.6%
Net MarginNet income ÷ Revenue+31.1%-349.6%-4.8%-156.4%
FCF MarginFCF ÷ Revenue+41.5%-227.0%-16.0%-2.1%
Rev. Growth (YoY)Latest quarter vs prior year+13.2%-26.9%+27.3%-39.3%
EPS Growth (YoY)Latest quarter vs prior year+63.5%+59.5%-55.6%+10.5%
BZ leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

Evenly matched — BZ and ASTS and RCUS each lead in 1 of 3 comparable metrics.

At 10.0x trailing earnings, SPIR trades at a 64% valuation discount to BZ's 27.6x P/E.

MetricBZ logoBZKanzhun LimitedSPIR logoSPIRSpire Global, Inc.ASTS logoASTSAST SpaceMobile, …RCUS logoRCUSArcus Biosciences…
Market CapShares × price$12.4B$529.9B$19.1B$2.5B
Enterprise ValueMkt cap + debt − cash$12.0B$513.8B$16.8B$2.4B
Trailing P/EPrice ÷ TTM EPS27.61x10.01x-48.76x-7.54x
Forward P/EPrice ÷ next-FY EPS est.1.67x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple44.10x
Price / SalesMarket cap ÷ Revenue11.45x7405.21x269.64x10.11x
Price / BookPrice ÷ Book value/share2.92x4.56x5.68x4.22x
Price / FCFMarket cap ÷ FCF31.36x
Evenly matched — BZ and ASTS and RCUS each lead in 1 of 3 comparable metrics.

Profitability & Efficiency

BZ leads this category, winning 5 of 9 comparable metrics.

BZ delivers a 14.9% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $-88 for SPIR. ASTS carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to RCUS's 0.16x. On the Piotroski fundamental quality scale (0–9), BZ scores 7/9 vs RCUS's 0/9, reflecting strong financial health.

MetricBZ logoBZKanzhun LimitedSPIR logoSPIRSpire Global, Inc.ASTS logoASTSAST SpaceMobile, …RCUS logoRCUSArcus Biosciences…
ROE (TTM)Return on equity+14.9%-88.4%-21.1%-69.0%
ROA (TTM)Return on assets+11.7%-47.3%-12.6%-35.3%
ROICReturn on invested capital+7.3%-0.1%-47.1%-64.1%
ROCEReturn on capital employed+8.2%-0.1%-10.0%-42.1%
Piotroski ScoreFundamental quality 0–97550
Debt / EquityFinancial leverage0.02x0.08x0.01x0.16x
Net DebtTotal debt minus cash-$2.3B-$16.1B-$2.3B-$123M
Cash & Equiv.Liquid assets$2.6B$24.8B$2.3B$222M
Total DebtShort + long-term debt$302M$8.8B$32M$99M
Interest CoverageEBIT ÷ Interest expense9.20x-21.20x-13.38x
BZ leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

ASTS leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in ASTS five years ago would be worth $78,824 today (with dividends reinvested), compared to $2,035 for SPIR. Over the past 12 months, RCUS leads with a +209.6% total return vs BZ's -9.4%. The 3-year compound annual growth rate (CAGR) favors ASTS at 134.8% vs BZ's -7.5% — a key indicator of consistent wealth creation.

MetricBZ logoBZKanzhun LimitedSPIR logoSPIRSpire Global, Inc.ASTS logoASTSAST SpaceMobile, …RCUS logoRCUSArcus Biosciences…
YTD ReturnYear-to-date-31.9%+106.4%-21.7%+6.5%
1-Year ReturnPast 12 months-9.4%+73.1%+158.1%+209.6%
3-Year ReturnCumulative with dividends-20.8%+198.1%+1194.0%+24.9%
5-Year ReturnCumulative with dividends-60.8%-79.6%+688.2%-18.6%
10-Year ReturnCumulative with dividends-60.8%-78.8%+568.8%+45.9%
CAGR (3Y)Annualised 3-year return-7.5%+43.9%+134.8%+7.7%
ASTS leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — BZ and RCUS each lead in 1 of 2 comparable metrics.

BZ is the less volatile stock with a 1.22 beta — it tends to amplify market swings less than SPIR's 2.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. RCUS currently trades 86.3% from its 52-week high vs ASTS's 50.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricBZ logoBZKanzhun LimitedSPIR logoSPIRSpire Global, Inc.ASTS logoASTSAST SpaceMobile, …RCUS logoRCUSArcus Biosciences…
Beta (5Y)Sensitivity to S&P 5001.22x2.93x2.82x1.95x
52-Week HighHighest price in past year$25.26$23.59$129.89$28.72
52-Week LowLowest price in past year$12.85$6.60$22.47$7.06
% of 52W HighCurrent price vs 52-week peak+56.4%+68.3%+50.3%+86.3%
RSI (14)Momentum oscillator 0–10059.355.541.860.5
Avg Volume (50D)Average daily shares traded3.7M1.6M14.9M1.2M
Evenly matched — BZ and RCUS each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: BZ as "Buy", SPIR as "Buy", ASTS as "Buy", RCUS as "Buy". Consensus price targets imply 96.6% upside for BZ (target: $28) vs 7.0% for SPIR (target: $17).

MetricBZ logoBZKanzhun LimitedSPIR logoSPIRSpire Global, Inc.ASTS logoASTSAST SpaceMobile, …RCUS logoRCUSArcus Biosciences…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuy
Price TargetConsensus 12-month target$28.00$17.25$103.65$30.00
# AnalystsCovering analysts912718
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises1
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+2.0%0.0%0.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

BZ leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ASTS leads in 1 (Total Returns). 2 tied.

Best OverallKanzhun Limited (BZ)Leads 2 of 6 categories
Loading custom metrics...

BZ vs SPIR vs ASTS vs RCUS: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is BZ or SPIR or ASTS or RCUS a better buy right now?

For growth investors, AST SpaceMobile, Inc.

(ASTS) is the stronger pick with 1505% revenue growth year-over-year, versus -35. 2% for Spire Global, Inc. (SPIR). Spire Global, Inc. (SPIR) offers the better valuation at 10. 0x trailing P/E, making it the more compelling value choice. Analysts rate Kanzhun Limited (BZ) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — BZ or SPIR or ASTS or RCUS?

On trailing P/E, Spire Global, Inc.

(SPIR) is the cheapest at 10. 0x versus Kanzhun Limited at 27. 6x.

03

Which is the better long-term investment — BZ or SPIR or ASTS or RCUS?

Over the past 5 years, AST SpaceMobile, Inc.

(ASTS) delivered a total return of +688. 2%, compared to -79. 6% for Spire Global, Inc. (SPIR). Over 10 years, the gap is even starker: ASTS returned +568. 8% versus SPIR's -78. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — BZ or SPIR or ASTS or RCUS?

By beta (market sensitivity over 5 years), Kanzhun Limited (BZ) is the lower-risk stock at 1.

22β versus Spire Global, Inc. 's 2. 93β — meaning SPIR is approximately 140% more volatile than BZ relative to the S&P 500. On balance sheet safety, AST SpaceMobile, Inc. (ASTS) carries a lower debt/equity ratio of 1% versus 16% for Arcus Biosciences, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — BZ or SPIR or ASTS or RCUS?

By revenue growth (latest reported year), AST SpaceMobile, Inc.

(ASTS) is pulling ahead at 1505% versus -35. 2% for Spire Global, Inc. (SPIR). On earnings-per-share growth, the picture is similar: Spire Global, Inc. grew EPS 137. 8% year-over-year, compared to -4. 8% for Arcus Biosciences, Inc.. Over a 3-year CAGR, ASTS leads at 72. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — BZ or SPIR or ASTS or RCUS?

Spire Global, Inc.

(SPIR) is the more profitable company, earning 71. 7% net margin versus -482. 2% for AST SpaceMobile, Inc. — meaning it keeps 71. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BZ leads at 15. 9% versus -405. 7% for ASTS. At the gross margin level — before operating expenses — RCUS leads at 96. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is BZ or SPIR or ASTS or RCUS more undervalued right now?

Analyst consensus price targets imply the most upside for BZ: 96.

6% to $28. 00.

08

Which pays a better dividend — BZ or SPIR or ASTS or RCUS?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is BZ or SPIR or ASTS or RCUS better for a retirement portfolio?

For long-horizon retirement investors, Kanzhun Limited (BZ) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

22)). Spire Global, Inc. (SPIR) carries a higher beta of 2. 93 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BZ: -60. 8%, SPIR: -78. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between BZ and SPIR and ASTS and RCUS?

These companies operate in different sectors (BZ (Industrials) and SPIR (Industrials) and ASTS (Technology) and RCUS (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: BZ is a mid-cap high-growth stock; SPIR is a large-cap deep-value stock; ASTS is a mid-cap high-growth stock; RCUS is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

BZ

Quality Mega-Cap Compounder

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 6%
  • Net Margin > 18%
Run This Screen
Stocks Like

SPIR

Quality Business

  • Sector: Industrials
  • Market Cap > $100B
  • Gross Margin > 24%
Run This Screen
Stocks Like

ASTS

High-Growth Disruptor

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 1365%
  • Gross Margin > 32%
Run This Screen
Stocks Like

RCUS

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 54%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform BZ and SPIR and ASTS and RCUS on the metrics below

Revenue Growth>
%
(BZ: 13.2% · SPIR: -26.9%)
P/E Ratio<
x
(BZ: 27.6x · SPIR: 10.0x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.